Back to History

Fields Changed

Registration

Field Before After
Trial Status completed on_going
Trial End Date October 25, 2019 October 02, 2020
Last Published February 13, 2020 01:00 AM February 13, 2020 07:01 AM
Intervention End Date October 25, 2019 October 02, 2020
Sample size (or number of clusters) by treatment arms Study 1 (343): 103 baseline; 86 all-or-nothing; 154 self-select Study 2 (406): 132 baseline; 131 all-or-nothing; 143 self-select Study 3 (336): 103 baseline; 131 self-select (no encouragement); 102 self-select (with encouragement) Study 4 (500): 114 baseline; 198 self-select (no bonus); 188 self-select (with bonus) Study 5 (373): 114 baseline; 146 self-select (no encouragement); 113 self-select (with encouragement) Study 6 (549): Phase 1 132 baseline; 417 self-select (encouragement) Phase 2 (207): 207 self-select (encouragement) Study 1 (343): 103 baseline; 86 all-or-nothing; 154 self-select Study 2 (406): 132 baseline; 131 all-or-nothing; 143 self-select Study 3 (336): 103 baseline; 131 self-select (no encouragement); 102 self-select (with encouragement) Study 4 (500): 114 baseline; 198 self-select (no bonus); 188 self-select (with bonus) Study 5 (373): 114 baseline; 146 self-select (no encouragement); 113 self-select (with encouragement) Study 6 (549): Phase 1 132 baseline; 417 self-select (encouragement) Phase 2 (207): 207 self-select (encouragement) 2020 (planned) Phase 1 (Introductory micro class): 130 baseline; 420 self-select (encouragement) Phase 2(Introductory macro class): 420 self-select (encouragement)
Back to top